Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

MSE PRO 1,3,8-Triazaspiro[4.5]decan-2-one, ≥97.0% Purity– MSE Supplies LLC

Overstock Sale - Select Products 10% Off on Orders of $500 or More! Promo Code:

SAVING10

Shop Now
Menu
Cart

This product has been added to the cart.

MSE PRO 1,3,8-Triazaspiro[4.5]decan-2-one, ≥97.0% Purity - MSE Supplies LLC

MSE PRO 1,3,8-Triazaspiro[4.5]decan-2-one, ≥97.0% Purity

SKU: CM1385

  • $ 41995
  • Save $ 5105

MSE PRO™ 1,3,8-Triazaspiro[4.5]decan-2-one, ≥97.0% Purity

MSE PRO™ 1,3,8-Triazaspiro[4.5]decan-2-one is a versatile and valuable chemical building block with a range of potential applications. The unique spiro ring system containing three nitrogen atoms and a carbonyl group gives this molecule distinct structural and electronic properties. Its versatile structure and availability of derivatives make it an attractive option for a wide range of applications, from pharmaceuticals to materials science.

MSE Supplies offers various N-heterocyclic drug small molecules and other chemical reagents. Please contact us for bulk orders.

Technical Specifications:

CAS No. 561314-52-1
Chemical name 1,3,8-Triazaspiro[4.5]decan-2-one
Synonym(s)
  • 1,3,8-triaza-spiro[4.5]decan-2-one
  • 2,4,8-triazaspiro[4.5]decan-3-one
Molecular formula C7H13N3O     
Pack size

1 g (CM1385)
Molecular weight 155.20 g/mol
Purity ≥97.0% (NMR) 
Boiling point 418.3±45.0 °C (Predicted)
Density 1.21±0.1g/cm3 (Predicted)
Appearance White to off-white solid
Storage  2-8 °C, protect from light


References:

[1] Dolbois, A., Bedi, R. K., Bochenkova, E., Müller, A., Moroz-Omori, E. V., Huang, D., & Caflisch, A. (2021). 1, 4, 9-Triazaspiro [5.5] undecan-2-one derivatives as potent and selective METTL3 inhibitors. Journal of Medicinal Chemistry, 64(17), 12738-12760.

[2] Mehrotra, M. M., Heath, J. A., Smyth, M. S., Pandey, A., Rose, J. W., Seroogy, J. M., ... & Scarborough, R. M. (2004). Discovery of novel 2, 8-diazaspiro [4.5] decanes as orally active glycoprotein IIb-IIIa antagonists. Journal of medicinal chemistry, 47(8), 2037-2061.